Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1976 Jun;13(6):1761–1770. doi: 10.1128/iai.13.6.1761-1770.1976

Gastrointestinal candidiasis in rats treated with antibiotics, cortisone, and azathioprine.

A DeMaria, H Buckley, F von Lichtenberg
PMCID: PMC420829  PMID: 786882

Abstract

Conventional albino rats treated with peroral chloramphenicol, gentamicin, and/or parenteral cortisone were challenged with Candida albicans Antibiotics and cortisone were equally effective in predisposing the animals to colonization by the fungus. All animals treated with both antibiotics and cortisone developed defined, focal, superficial invasion of the cornified squamous epithelium of the stomach next to its junction with the glandular mucosa, as well as focal superficial invasion of the esophagus. Equivalent yeast cell and mycelial inocula of C. albicans were equally effective in producing colonization and invasion of the gut. Dissemination of the fungus from the gut was not found even after the addition of azathioprine to the treatment regimen; however, such addition did predispose to more extensive and severe lesions of the esophagus and stomach. Approximately 25% of infected cortisone- and antibiotic-treated rats developed agglutinins against C. albicans by 22 to 23 days after challenge, whereas 15% developed precipitins. The antibiotic-cortisone-treated rat may be a useful and consistent experimental model in the study of gastrointestinal candidiasis.

Full text

PDF
1761

Images in this article

1766Image
on p.1766
1766Image
on p.1766
1767Image
on p.1767
1767Image
on p.1767
1768Image
on p.1768

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Balish E., Phillips A. W. Growth and virulence of Candida albicans after oral inoculation in the chick with a monoflora of either Escherichia coli or Streptococcus faecalis. J Bacteriol. 1966 May;91(5):1744–1749. doi: 10.1128/jb.91.5.1744-1749.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Balish E., Phillips A. W. Growth, morphogenesis, and virulence of Candida albicans after oral inoculation in the germ-free and conventional chick. J Bacteriol. 1966 May;91(5):1736–1743. doi: 10.1128/jb.91.5.1736-1743.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Büttner D. W., Matthiessen B. Gelangen lebende Hefezellen beim Gesunden regelmässig aus dem Darmlumen in die Blutbahn? Mykosen. 1969 Jun 1;12(6):387–390. [PubMed] [Google Scholar]
  4. Chew W. H., Theus T. L. Candida precipitins. J Immunol. 1967 Feb;98(2):220–224. [PubMed] [Google Scholar]
  5. Chilgren R. A., Hong R., Quie P. G. Human serum interactions with Candida albicans. J Immunol. 1968 Jul;101(1):128–132. [PubMed] [Google Scholar]
  6. Claman H. N. Corticosteroids and lymphoid cells. N Engl J Med. 1972 Aug 24;287(8):388–397. doi: 10.1056/NEJM197208242870806. [DOI] [PubMed] [Google Scholar]
  7. Clark J. D. Influence of antibiotics or certain intestinal bacteria on orally administered Candida albicans in germ-free and conventional mice. Infect Immun. 1971 Dec;4(6):731–737. doi: 10.1128/iai.4.6.731-737.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Eras P., Goldstein M. J., Sherlock P. Candida infection of the gastrointestinal tract. Medicine (Baltimore) 1972 Sep;51(5):367–379. doi: 10.1097/00005792-197209000-00002. [DOI] [PubMed] [Google Scholar]
  9. FRENKEL J. K. Role of corticosteroids as predisposing factors in fungal diseases. Lab Invest. 1962 Nov;11:1192–1208. [PubMed] [Google Scholar]
  10. Folb P. I., Trounce J. R. Immunological aspects of candida infection complicating steroid and immunosuppressive drug therapy. Lancet. 1970 Nov 28;2(7683):1112–1114. doi: 10.1016/s0140-6736(70)92299-3. [DOI] [PubMed] [Google Scholar]
  11. HUPPERT M., CAZIN J., Jr, SMITH H., Jr Pathogenesis of Candida albicans infection following antibiotic therapy. III. The effect of antibiotics on the incidence of Candida albicans in the intestinal tract of mice. J Bacteriol. 1955 Oct;70(4):440–447. doi: 10.1128/jb.70.4.440-447.1955. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hart P. D., Russell E., Jr, Remington J. S. The compromised host and infection. II. Deep fungal infection. J Infect Dis. 1969 Aug;120(2):169–191. doi: 10.1093/infdis/120.2.169. [DOI] [PubMed] [Google Scholar]
  13. Hummel R. P., Oestreicher E. J., Maley M. P., Macmillan B. G. Inhibition of Candida albicans by Escherichia coli in vitro and in the germfree mouse. J Surg Res. 1973 Jul;15(1):53–58. doi: 10.1016/0022-4804(73)90163-7. [DOI] [PubMed] [Google Scholar]
  14. Hurd E. R. Immunosuppressive and antiinflammatory properties of cyclophosphamide, azathioprine and methotrexate. Arthritis Rheum. 1973 Jan-Feb;16(1):84–88. doi: 10.1002/art.1780160114. [DOI] [PubMed] [Google Scholar]
  15. Jones J. H., Adams D. Experimentally induced acute oral candidosis in the rat. Br J Dermatol. 1970 Dec;83(6):670–673. doi: 10.1111/j.1365-2133.1970.tb15762.x. [DOI] [PubMed] [Google Scholar]
  16. Jones J. H., Russell C. Experimental oral candidiasis in weanling rats. J Dent Res. 1973 Jan-Feb;52(1):182–182. doi: 10.1177/00220345730520012001. [DOI] [PubMed] [Google Scholar]
  17. Knight L., Fletcher J. Growth of Candida albicans in saliva: stimulation by glucose associated with antibiotics, corticosteroids, and diabetes mellitus. J Infect Dis. 1971 Apr;123(4):371–377. doi: 10.1093/infdis/123.4.371. [DOI] [PubMed] [Google Scholar]
  18. Krause W., Matheis H., Wulf K. Fungaemia and funguria after oral administration of Candida albicans. Lancet. 1969 Mar 22;1(7595):598–599. doi: 10.1016/s0140-6736(69)91534-7. [DOI] [PubMed] [Google Scholar]
  19. Lee K. L., Buckley H. R., Campbell C. C. An amino acid liquid synthetic medium for the development of mycelial and yeast forms of Candida Albicans. Sabouraudia. 1975 Jul;13(2):148–153. doi: 10.1080/00362177585190271. [DOI] [PubMed] [Google Scholar]
  20. Lehner T., Buckley H. R., Murray I. G. The relationship between fluorescent, agglutinating, and precipitating antibodies to Candida albicans and their immunoglobulin classes. J Clin Pathol. 1972 Apr;25(4):344–348. doi: 10.1136/jcp.25.4.344. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. MENGUY R., MASTERS Y. F. Effect of cortisone on mucoprotein secretion by gastric antrum of dogs: pathogenesis of steroid ulcer. Surgery. 1963 Jul;54:19–28. [PubMed] [Google Scholar]
  22. Murray I. G., Buckley H. R., Turner G. C. Serological evidence of Candida infection after open-heart surgery. J Med Microbiol. 1969 Nov 4;2(4):463–469. doi: 10.1099/00222615-2-4-463. [DOI] [PubMed] [Google Scholar]
  23. Nishikawa T., Hatano H., Ohnishi N., Sasaki S., Nomura T. Establishment of Candida albicans in the alimentary tract of the germ-free mice and antagonism with Escherichia coli after oral inoculation. Jpn J Microbiol. 1969 Sep;13(3):263–276. doi: 10.1111/j.1348-0421.1969.tb00466.x. [DOI] [PubMed] [Google Scholar]
  24. Preisler H. D., Hasenclever H. F., Henderson E. S. Anti-Candida antibodies in patients with acute leukemia. A prospective study. Am J Med. 1971 Sep;51(3):352–361. doi: 10.1016/0002-9343(71)90271-3. [DOI] [PubMed] [Google Scholar]
  25. Preisler H. D., Hasenclever H. F., Levitan A. A., Henderson E. S. Serologic diagnosis of disseminated candidiasis in patients with acute leukemia. Ann Intern Med. 1969 Jan;70(1):19–30. doi: 10.7326/0003-4819-70-1-19. [DOI] [PubMed] [Google Scholar]
  26. Remington J. S., Gaines J. D., Gilmer M. A. Demonstration of Candida precipitins in human sera by counterimmunoelectrophoresis. Lancet. 1972 Feb 19;1(7747):413–413. doi: 10.1016/s0140-6736(72)90860-4. [DOI] [PubMed] [Google Scholar]
  27. Rifkind D., Marchioro T. L., Schneck S. A., Hill R. B., Jr Systemic fungal infections complicating renal transplantation and immunosuppressive therapy. Clinical, microbiologic, neurologic and pathologic features. Am J Med. 1967 Jul;43(1):28–38. doi: 10.1016/0002-9343(67)90146-5. [DOI] [PubMed] [Google Scholar]
  28. Rosener F., Gabriel F. D., Taschdjian C., Cuesta M. B., Kozinn P. J. Serologic diagnosis of systemic candidiasis in patients with acute leukemia. Am J Med. 1971 Jul;51(1):54–62. doi: 10.1016/0002-9343(71)90323-8. [DOI] [PubMed] [Google Scholar]
  29. Russell C., Jones J. H. Effects of oral inoculation of Candida albicans in tetracycline-treated rats. J Med Microbiol. 1973 Aug;6(3):275–279. doi: 10.1099/00222615-6-3-275. [DOI] [PubMed] [Google Scholar]
  30. Russell C., Jones J. H. The effects of oral inoculation of the yeast and mycelial phases of Candida albicans in rats fed on normal and carbohydrate rich diets. Arch Oral Biol. 1973 Mar;18(3):409–412. doi: 10.1016/0003-9969(73)90165-9. [DOI] [PubMed] [Google Scholar]
  31. SELIGMANN E. Virulence enhancing activities of aureomycin on Candida albicans. Proc Soc Exp Biol Med. 1952 Mar;79(3):481–484. doi: 10.3181/00379727-79-19418. [DOI] [PubMed] [Google Scholar]
  32. SIEBURTH J. M., ROTH F. J., Jr The effect of aureomycin and terramycin on Candida albicans in the fecal microflora of chicks and turkey poults. J Bacteriol. 1954 Apr;67(4):460–464. doi: 10.1128/jb.67.4.460-464.1954. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. STALLYBRASS F. C. CANDIDA PRECIPITINS. J Pathol Bacteriol. 1964 Jan;87:89–97. doi: 10.1002/path.1700870113. [DOI] [PubMed] [Google Scholar]
  34. Seelig M. S. Mechanisms by which antibiotics increase the incidence and severity of candidiasis and alter the immunological defenses. Bacteriol Rev. 1966 Jun;30(2):442–459. doi: 10.1128/br.30.2.442-459.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Stanley V. C., Hurley R., Carroll C. J. Distribution and significance of candida precipitins in sera from pregnant women. J Med Microbiol. 1972 Aug;5(3):313–320. doi: 10.1099/00222615-5-3-313. [DOI] [PubMed] [Google Scholar]
  36. Stone H. H., Geheber C. E., Kolb L. D., Kitchens W. R. Alimentary tract colonization by Candida albicans. J Surg Res. 1973 Apr;14(4):273–276. doi: 10.1016/0022-4804(73)90028-0. [DOI] [PubMed] [Google Scholar]
  37. TASCHDJIAN C. L., REISS F., KOZINN P. J. Experimental vaginal candidiasis in mice; its implications for superficial candidiasis in humans. J Invest Dermatol. 1960 Feb;34:89–94. [PubMed] [Google Scholar]
  38. Taschdjian C. L., Kozinn P. J., Cuesta M. B., Toni E. F. Serodiagnosis of Candidal infections. Am J Clin Pathol. 1972 Feb;57(2):195–205. doi: 10.1093/ajcp/57.2.195. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES